The NAMS Statement on Continuing Use of Systemic Hormone Therapy After Age 65
7 April 2015
...Use of HT should be individualized and not discontinued solely based on a woman’s age... Members only access
Short-term use of hormone replacement therapy (HRT) and ovarian cancer risk
17 February 2015
..."This recent meta-analysis from the Collaborative Group raises the possibility of an increased risk of ovarian cancer with use of estrogen or combined estrogen-progestogen therapy.
...In the days since the study was released examination of the relative and absolute risk calculations have shown them to be incorrect. The revised absolute risk increase appears to now sit at just under 1 extra case per 10,000 women per year; somewhat less than the study initially suggested. Read more...